| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18K | — | +0.0% |
| Cost of Revenue | $21K | — | +1317.0% |
| Gross Profit | -$3K | — | -116.1% |
| R&D Expense | $1.0M | — | +70.6% |
| SG&A Expense | $1.6M | — | +43.3% |
| Operating Income | -$1.6M | — | -45.7% |
| Pre-tax Income | -$1.6M | — | -59.7% |
| Net Income | -$1.6M | — | -59.7% |
| EPS (Basic) | -$0.12 | — | +47.8% |
| EPS (Diluted) | -$0.12 | — | +47.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.9M | -17.8% | +24.4% |
| Short-term Investments | $2.1M | +0.9% | -8.0% |
| Current Assets | $6.8M | -7.9% | +21.4% |
| Total Assets | $7.0M | -7.7% | +19.0% |
| Current Liabilities | $705K | +8.4% | -40.5% |
| Total Liabilities | $1.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$823K | — | +49.8% |
| Investing Cash Flow | -$24K | — | -102.7% |
| -29.3% |
| Stockholders' Equity | $5.7M | -9.9% | +41.7% |